Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Banting Postdoctoral Fellowship Program

University of Calgary

$140,000.00

Imaging the behavior of peritoneal macrophages under homeostasis and in liver metastasis.

EF 2018-19

Résumé
It is well known that an immune cell called the monocyte in blood can enter into the tumor become a macrophage and help the tumor grow. Drugs including immunotherapeutics are being developed to stop these cells from coming into the tumor. However, there may be a backdoor! Macrophages also live in the space that surrounds the tissue in which the tumor is growing such as the peritoneal cavity. These are repair macrophages and in our preliminary work, we have reported that these macrophages are potent healer cells and that they can infiltrate into colon carcinoma liver metastases. Since the peritoneal macrophages get recruited to the site of injury and initiate the healing process, they may even infiltrate into the tumors partially killed by ablation therapy and help repair. However, they do not enter through blood but rather invade directly through the tissue via molecules that are not being targeted therapeutically. Using mouse models of colon cancer liver metastases, we will use our very sophisticated microscopes to be able to visualize the growing tumors inside liver and track a specific immune cell, the peritoneal macrophages which will glow because we have introduced a fluorescent gene into the mouse genome. We will see if the tumors have a greater difficulty metastasizing and growing in the absence of these cells. We also think that to target these cells we may either need novel drugs or at the very least different delivery of existing drugs. We will test whether placing immunotherapies into the blood versus into the cavity versus into both sites will derive different results. With huge attention being placed on immunotherapy and on preventing macrophages from entering into tumors from the blood stream, it would be a shame if poor outcomes were simply due to not delivering the drug in an optimal way. We believe that our research has the potential to improve success rates for immunotherapy by considering the peritoneal cavity as a portal of entry into tumors.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
394104
Name
Hossain Mokarram
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Imaging the behavior of peritoneal macrophages under homeostasis and in liver metastasis.
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Colorectal Cancer Liver Metastasis; Immunotherapy; Pd-L1; Pd1; Peritoneal Macrophages; Tumor Ablation; Tumor-Associated Macrophages
Abstract
It is well known that an immune cell called the monocyte in blood can enter into the tumor become a macrophage and help the tumor grow. Drugs including immunotherapeutics are being developed to stop these cells from coming into the tumor. However, there may be a backdoor! Macrophages also live in the space that surrounds the tissue in which the tumor is growing such as the peritoneal cavity. These are repair macrophages and in our preliminary work, we have reported that these macrophages are potent healer cells and that they can infiltrate into colon carcinoma liver metastases. Since the peritoneal macrophages get recruited to the site of injury and initiate the healing process, they may even infiltrate into the tumors partially killed by ablation therapy and help repair. However, they do not enter through blood but rather invade directly through the tissue via molecules that are not being targeted therapeutically. Using mouse models of colon cancer liver metastases, we will use our very sophisticated microscopes to be able to visualize the growing tumors inside liver and track a specific immune cell, the peritoneal macrophages which will glow because we have introduced a fluorescent gene into the mouse genome. We will see if the tumors have a greater difficulty metastasizing and growing in the absence of these cells. We also think that to target these cells we may either need novel drugs or at the very least different delivery of existing drugs. We will test whether placing immunotherapies into the blood versus into the cavity versus into both sites will derive different results. With huge attention being placed on immunotherapy and on preventing macrophages from entering into tumors from the blood stream, it would be a shame if poor outcomes were simply due to not delivering the drug in an optimal way. We believe that our research has the potential to improve success rates for immunotherapy by considering the peritoneal cavity as a portal of entry into tumors.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hossain, Mokarram
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~